2Watanabe T, Tada M, Nagai H, Sasaki S, NakaoM. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology, 1998, 115: 642～648.
3Tokieda M, Honda S, Fujioka T, Nasu M. Effect of Helicobacter pylori infection on the N-methylN-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in mongolian gerbils. Carcinogenesis, 1999, 20: 1261～1266.
4Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 2001, 345: 784～789.
5LamSK.胃癌预防的研究方向[J].胃肠病学,2001,6:11-11.
6Tuech JJ, Cervi C, Pessaux P, Villapadierna F, Bergamaschi R, Ronceray J, Arnaud JP. Early gastric cancer: univariate and multivariate analysis for survival. Hepatogastroenterology, 1999, 46: 3276～3280.
7Akahoshi K, Chijiiwa Y, Hamada S, Sasaki I, Maruoka A, Kabemura T, Nawata H. Endoscopic ultrasonography: a promising method for assessing the prospects of endoscopic mucosal resection in early gastric cancer. Endoscopy, 1997, 29: 614～ 619.
6Yang YL, Ye YM, Li FM, Li YF, Ma PZ. Characteristic autofluorescence for cancer diagnosis and its origin. Lasers Surg Med, 1987, 7: 528～532.
7Cothren RM, Sivak MV Jr, Van Dam J, Petras RE, Fitzmaurice M, Crawford JM, Wu J, Brennan F, Rava RP. Detection of dysplasia at colonoscopy using laser-induced fluorescence: a blinded study. Gastrointest Endosc, 1996, 44: 168～176.
8DaCosta RS, Lilge L, Kost J, Cirocco M, Saidi R,DaVall GA, Hassarom S, Kandel G, Kortan P, Haber G, Mang T, Marcon N, Wilson BC. Confocal fluorescence microscopy (CFM) and modeling of tissue changes in laser induced fluorescence endoscopy (LIFE) of human esophageal, gastric and colonic neoplasias. Gastroenterology, 1998,114: A583.
9Izuishi K, Tajiri H, Fujii T, Abe S, Ryum, Yoshidas. The basic for the decreased autofluorescence of adenoma and cancer of the colon by laserinduced fluorescence endoscopy. Gastroenterology,1998, 114: A615.
7Vivanco I, Sawyers C L. The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer [J]. Nat Rev Cancer, 2002,2 (7) : 489- 501.
8Roymans D, Slegers H. Phosphatidylinositol 3-kinases in Tumor Progression[J]. Eur J Biochem,2001,268(3) :487-491.
9Arcaro A, Zvelebil M J, Wallasch C, et al. Class II Phosphoinositide 3-kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors[J]. Mol Cell Biol, 2000, 20 (11) 3817-3830.
10Cantley L C. The Phosphoinositide 3-kinase Pathway[J]. Science,2002,296(5573) :1655-1657.
